
AI for Drug Discovery
Rui Wang · 王锐
EVP, Global Head of In Silico & AI, Evotec
Leads enterprise-scale AI drug discovery at Evotec; previously Head of Data, Analytics and AI at AstraZeneca.
LinkedInEvents · First Workshop
Our first workshop brings together six speakers spanning the full chain from the compute infrastructure beneath AI to its scientific applications — around a single throughline: trustworthy, usable, and affordable intelligence in the service of health, education, and scientific discovery.
Speakers

AI for Drug Discovery
EVP, Global Head of In Silico & AI, Evotec
Leads enterprise-scale AI drug discovery at Evotec; previously Head of Data, Analytics and AI at AstraZeneca.
LinkedIn
Embodied Intelligence
Assistant Professor, University of Galway · Research Associate, University of Cambridge
Works on embodied intelligence that unites world models with LLM reasoning for robot perception and control.
Homepage
Bioengineering
Founder, ONECARBON · Cambridge Stem Cell Institute
Develops AI-driven probiotic therapies for neurodegenerative disease as a computational biologist and founder.
Homepage
Voice AI
PhD, Department of Engineering, University of Cambridge
Builds adaptive spoken-dialogue systems for language learning; formerly Senior ML Engineer at Cambridge University Press & Assessment.
LinkedIn
ML for Materials
PhD, Department of Materials Science, University of Cambridge
Applies machine learning to electron-microscopy characterisation in the Electron Microscopy Group.
Google Scholar
Efficient LLM Systems
PhD, Department of Computer Science, University of Cambridge
Works on the AI-infrastructure and MLSys layer beneath efficient large language models — distributed systems, LLM serving, and large-scale training — with recent work at OSDI, ICML, ICLR, and MLSys.
HomepageSponsors & Supporters